Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.5506
-0.0191-3.35%
Volume:23.24K
Turnover:13.02K
Market Cap:18.32M
PE:-0.59
High:0.5726
Open:0.5626
Low:0.5496
Close:0.5697
52wk High:2.69
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:0.34
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:12.97
PE(LYR):-0.14

Loading ...

Corrected-Jasper Therapeutics - Offer Purchase Price is $0.324 (Not '$0.32') in Cash Per Warrant

THOMSON REUTERS
·
Yesterday

Jasper Therapeutics Launches Cash Tender Offer to Buy Back Outstanding Warrants for $0.324 Each

Reuters
·
Yesterday

Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants

THOMSON REUTERS
·
Yesterday

Jasper Therapeutics Holds Special Shareholder Meeting

Reuters
·
Oct 05

Jasper Therapeutics - Appoints Jeet Mahal as Interim Principal Financial Officer Effective October 9, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 29

Jasper Therapeutics - Herb Cross Resigns as CFO and Corporate Secretary Effective October 9, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 29

Jasper Therapeutics CFO Herb Cross Resigns Effective Oct. 9

Reuters
·
Sep 29

H.C. Wainwright Remains a Buy on Jasper Therapeutics (JSPR)

TIPRANKS
·
Sep 22

Press Release: Jasper Therapeutics Announces Key Regulatory and Clinical Appointments

Dow Jones
·
Sep 16

Jasper Therapeutics to Join H.C. Wainwright Global Investment Conference Fireside Chat

Reuters
·
Sep 09

Jasper Therapeutics Announces Special Shareholder Meeting

Reuters
·
Sep 05

Jasper Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Aptevo Therapeutics (APVO) and Jasper Therapeutics (JSPR)

TIPRANKS
·
Aug 18

Jasper Therapeutics initiated with an Overweight at Piper Sandler

TIPRANKS
·
Aug 17

Novo, LightPath, Jasper, UMAC, CCEP Trending With Analysts

TIPRANKS
·
Aug 15

Jasper Therapeutics Q2 EPS $(0.10) Beats $(0.26) Estimate

Benzinga Earnings
·
Aug 15

Jasper Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Jasper Therapeutics Q2 Loss Per Share Beats Estimates, Raises $132 Mln

Reuters
·
Aug 14

Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 14

Jasper Therapeutics Q2 Net Income USD -2.8 Million

THOMSON REUTERS
·
Aug 14